Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Ono, Hirotaka, Kawano, Tadamichi, Yoshida, Yuji, Okubo, Tomomi, Hayama, Korenobu, Nakagawa‐Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Nagao, Mototsugu, Iwakiri, Katsuhiko
Publicado 2022

General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after...

por Tada, Toshifumi, Kurosaki, Masayuki, Tamaki, Nobuharu, Yasui, Yutaka, Mori, Nami, Tsuji, Keiji, Hasebe, Chitomi, Joko, Koji, Akahane, Takehiro, Furuta, Koichiro, Kobashi, Haruhiko, Fujii, Hideki, Ishii, Toru, Marusawa, Hiroyuki, Kondo, Masahiko, Kojima, Yuji, Yoshida, Hideo, Uchida, Yasushi, Nakamura, Shinichiro, Izumi, Namiki
Publicado 2022

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients

por Toshida, Katsuya, Itoh, Shinji, Tomiyama, Takahiro, Morinaga, Akinari, Kosai, Yukiko, Tomino, Takahiro, Kurihara, Takeshi, Nagao, Yoshihiro, Morita, Kazutoyo, Harada, Noboru, Yoshizumi, Tomoharu
Publicado 2022

Characteristics of hepatocellular carcinoma in patients with hepatitis C virus who received direct‐acting antiviral therapy and achieved sustained virological response: The impact...

por Tada, Toshifumi, Kumada, Takashi, Matono, Tomomitsu, Nakamura, Shinichiro, Sue, Masahiko, Matsuo, Yu, Takatani, Masahiro, Iijima, Hiroko, Tanaka, Junko
Publicado 2022

Analysis of the albumin‐bilirubin score as an indicator of improved liver function among hepatitis C virus patients with sustained viral response after direct‐acting antiviral ther...

por Martínez Herreros, Ángela, Sangro, Bruno, García Rodriguez, Alba, Pérez Grijalba, Virginia
Publicado 2022

Two‐year efficacy of SNK01 plus pembrolizumab for non‐small cell lung cancer: Expanded observations from a phase I/IIa randomized controlled trial

por Park, Hyung Jun, Kim, Yong Man, Jung, Jae Seob, Ji, Wonjun, Lee, Jae Cheol, Choi, Chang‐Min
Publicado 2022

Predictive value of post‐treatment C‐reactive protein‐to‐albumin ratio in locally advanced non–small cell lung cancer patients receiving durvalumab after chemoradiotherapy...

por Araki, Taisuke, Tateishi, Kazunari, Komatsu, Masamichi, Sonehara, Kei, Wasamoto, Satoshi, Koyama, Shigeru, Yoshiike, Fumiaki, Hama, Mineyuki, Nishie, Kenichi, Kondo, Daichi, Agatsuma, Toshihiko, Kato, Akane, Takata, Munetake, Kanda, Shintaro, Hanaoka, Masayuki, Koizumi, Tomonobu
Publicado 2022

Angiosarcoma of breast and chest wall complicated with tuberculous empyema: A case report

por Gao, Xingchen, Liu, Haiyan, Wang, Feng, Xu, Ziwei, Han, Yi, Liu, Shuku
Publicado 2022

Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal squamous cell carcinoma: A propensity score‐matched analysis

por Cui, Chanjuan, Wu, Xi, Deng, Lei, Wang, Wenqing, Cui, Wei, Wang, Yanfeng
Publicado 2022

Outcome and prognosis of secondary lung cancer surgery with interstitial lung disease

por Ichinokawa, Hideomi, Takamochi, Kazuya, Fukui, Mariko, Hattori, Aritoshi, Matsunaga, Takeshi, Suzuki, Kenji
Publicado 2022

TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma

por Peng, Yue, Qiu, Bin, Tan, Fengwei, Xu, Jiachen, Bie, Fenglong, He, Huayu, Liu, Lei, Tian, He, Bai, Guangyu, Zhou, Bolun, Li, Yuan, Huai, Qilin, Yang, Zhenlin, Gao, Shugeng
Publicado 2022

A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma

por Ishida, Akane, Ushio, Ayumi, Hashimoto, Masao, Ishii, Satoru, Naka, Go, Iikura, Motoyasu, Izumi, Shinyu, Hojo, Masayuki, Sugiyama, Haruhito
Publicado 2022

Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first‐line setting

por Kwok, Wang Chun, Ho, James Chung Man, Tam, Terence Chi Chun, Ip, Mary Sau Man, Lam, David Chi Leung
Publicado 2022

Outcomes of patients with different lepidic percentage and tumor size of stage I lung adenocarcinoma

por Liu, Chia, Wang, Lei‐Chi, Chen, Hui‐Shan, Yeh, Yi‐Chen, Hsu, Po‐Kuei, Huang, Chien‐Sheng, Hsieh, Chih‐Cheng, Hsu, Han‐Shui
Publicado 2022

Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer

por Miyawaki, Taichi, Naito, Tateaki, Doshita, Kosei, Kodama, Hiroaki, Mori, Mikiko, Nishioka, Naoya, Iida, Yuko, Miyawaki, Eriko, Mamesaya, Nobuaki, Kobayashi, Haruki, Omori, Shota, Ko, Ryo, Wakuda, Kazushige, Ono, Akira, Kenmotsu, Hirotsugu, Murakami, Haruyasu, Mori, Keita, Harada, Hideyuki, Endo, Masahiro, Takahashi, Kazuhisa, Takahashi, Toshiaki
Publicado 2022

Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients

por Kanai, Hidetoshi, Nangaku, Masaomi, Nagai, Reiko, Okuda, Nobuhiko, Kurata, Kyo, Nagakubo, Takashi, Endo, Yukihiro, Cobitz, Alexander
Publicado 2021

Mental well‐being of staff in long‐term care facilities at risk

por Ura, Chiaki, Okamura, Tsuyoshi, Takase, Akinori, Shimmei, Masaya, Ogawa, Yukan
Publicado 2021

Two long‐term phase 3 studies of enarodustat (JTZ‐951) in Japanese anemic patients with chronic kidney disease not on dialysis or on maintenance hemodialysis: SYMPHONY ND‐Long and...

por Akizawa, Tadao, Nangaku, Masaomi, Yamaguchi, Takuhiro, Koretomo, Ryosuke, Maeda, Kazuo, Yamada, Osamu, Hirakata, Hideki
Publicado 2021

Molidustat for the treatment of anemia in Japanese patients undergoing peritoneal dialysis: a single‐arm, open‐label, phase 3 study

por Akizawa, Tadao, Nobori, Kiyoshi, Matsuda, Yoshimi, Taki, Kentaro, Hayashi, Yasuhiro, Hayasaki, Takanori, Yamamoto, Hiroyasu
Publicado 2021

Duration of untreated illness of patients with obsessive–compulsive disorder in Japan

por Matsumoto, Yoshihiro, Nakamae, Takashi, Abe, Yoshinari, Watanabe, Anri, Narumoto, Jin
Publicado 2020